We are live on ! Find out more
NXTM

NxStage Medical Inc.
NXTM

Delisted

NXTM was delisted on the 21st of February, 2019.

Back to rankings

163 hedge funds and large institutions have $1.55B invested in NxStage Medical Inc. in 2017 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 64 increasing their positions, 61 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

161% more call options, than puts

Call options by funds: $3.22M | Put options by funds: $1.23M

5% more repeat investments, than reductions

Existing positions increased: 64 | Existing positions reduced: 61

5% less funds holding

Funds holding: 171 → 163 (-8)

8% less capital invested

Capital invested by funds: $1.68B → $1.55B (-$128M)

30% less first-time investments, than exits

New positions opened: 19 | Existing positions closed: 27

43% less funds holding in top 10

Funds holding in top 10: 7 → 4 (-3)

Holders
163
Holders Change
-8
Holders Change %
-4.68%
% of All Funds
4.06%
Holding in Top 10
4
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-42.86%
% of All Funds
0.1%
New
19
Increased
64
Reduced
61
Closed
27
Calls
$3.22M
Puts
$1.23M
Net Calls
+$1.99M
Net Calls Change
+$1.1M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$58.9M
2
William Blair Investment Management
William Blair Investment Management
Illinois
+$40.3M
3
RG
Redmile Group
California
+$16.3M
4
Millennium Management
Millennium Management
New York
+$14.6M
5
EAM
Eagle Asset Management
Florida
+$13.4M

Top Sellers

Rank Fund Capital Flow
1
GGHC
Gilder Gagnon Howe & Co
New York
-$68.2M
2
Jennison Associates
Jennison Associates
New York
-$14.9M
3
PC
Polar Capital
United Kingdom
-$14.5M
4
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
-$14.5M
5
OIM
Oracle Investment Management
Connecticut
-$11M
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
51
Morgan Stanley
New York
$3.98M -$986K -39,832 -20%
Fidelity International
52
Fidelity International
Bermuda
$3.72M – – –
Ameriprise
53
Ameriprise
Minnesota
$3.49M -$139K -5,626 -4%
N
54
Nuveen
North Carolina
$3.41M +$614K +24,818 +22%
TA
55
Teachers Advisors
New York
$3.21M +$225K +9,074 +8%
TA
56
Tamarack Advisers
California
$3.2M +$433K +17,500 +16%
LOAMU
57
Lombard Odier Asset Management (USA)
New York
$3.09M +$1.32M +53,281 +76%
California State Teachers Retirement System (CalSTRS)
58
California State Teachers Retirement System (CalSTRS)
California
$2.88M -$256K -10,321 -8%
TAM
59
Tiverton Asset Management
Delaware
$2.78M -$914K -36,914 -25%
Swiss National Bank
60
Swiss National Bank
Switzerland
$2.75M +$89.1K +3,600 +3%
KIA
61
Kopp Investment Advisors
Minnesota
$2.75M -$204K -8,233 -7%
ECM
62
Endurant Capital Management
California
$2.71M +$2.68M +108,300 New
Carson Wealth (CWM LLC)
63
Carson Wealth (CWM LLC)
Nebraska
$2.68M +$2.65M +107,077 New
QI
64
QS Investors
New York
$2.63M -$19K -769 -0.7%
CIP
65
Chartwell Investment Partners
Pennsylvania
$2.54M +$941 +38 +0%
Goldman Sachs
66
Goldman Sachs
New York
$2.52M +$416K +16,817 +20%
CS
67
Credit Suisse
Switzerland
$2.49M +$1.41M +56,872 +134%
WMSA
68
Weiss Multi-Strategy Advisers
New York
$2.36M -$520K -21,000 -18%
AllianceBernstein
69
AllianceBernstein
Tennessee
$2.36M – – –
California Public Employees Retirement System
70
California Public Employees Retirement System
California
$2.33M -$124K -5,000 -5%
Two Sigma Investments
71
Two Sigma Investments
New York
$2.31M -$4.71M -190,408 -67%
Deutsche Bank
72
Deutsche Bank
Germany
$2.22M +$379K +15,313 +21%
OA
73
Outfitter Advisors
Virginia
$1.95M +$559K +22,570 +41%
RhumbLine Advisers
74
RhumbLine Advisers
Massachusetts
$1.94M +$2.85K +115 +0.1%
EU
75
Emory University
Georgia
$1.8M +$1.78M +71,954 New
1 2
3
4 5

NXTM Hedge Fund Activity: Q2 2017 in Review

163 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in NxStage Medical Inc. (NXTM) for Q2 2017, worth a combined $1.55B — down 7.7% from $1.68B a quarter earlier.

Sellers outnumbered buyers: 27 funds closed out of NXTM and 19 opened new positions — a net loss of 8 holders — while 61 trimmed existing stakes and 64 added.

The largest buyer was Fidelity Investments, adding an estimated $58.9M. The largest seller was Gilder Gagnon Howe & Co, cutting an estimated $68.2M.

  • 163 institutional investors held NxStage Medical Inc. (NXTM) as of Q2 2017, down from 171 in Q1 2017.
  • Funds reported $1.55B of NxStage Medical Inc. stock for Q2 2017, down 7.7% quarter-over-quarter.
  • 19 funds opened new NxStage Medical Inc. positions in Q2 2017 and 27 closed out, a net change of -8 holders.
  • The largest NxStage Medical Inc. buyer in Q2 2017 was Fidelity Investments, an estimated $58.9M added.
  • The largest NxStage Medical Inc. seller in Q2 2017 was Gilder Gagnon Howe & Co, an estimated $68.2M sold.

Based on aggregated 13F filings for Q2 2017.